The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis.
Takuya Koie
No relevant relationships to disclose
Teppei Okamoto
No relevant relationships to disclose
Yuichiro Suzuki
No relevant relationships to disclose
Yuki Tobisawa
No relevant relationships to disclose
Tohru Yoneyama
No relevant relationships to disclose
Kazuyuki Mori
No relevant relationships to disclose
Hayato Yamamoto
No relevant relationships to disclose
Shingo Hatakeyama
No relevant relationships to disclose
Takahiro Yoneyama
No relevant relationships to disclose
Noritaka Kamimura
No relevant relationships to disclose
Chikara Ohyama
No relevant relationships to disclose